Cogent Biosciences, Inc. (COGT)
34.75
-0.60
(-1.70%)
USD |
NASDAQ |
Jan 12, 16:00
34.75
0.00 (0.00%)
After-Hours: 18:04
Cogent Biosciences Research and Development Expense (Quarterly): 67.84M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| Cidara Therapeutics, Inc. | 35.53M |
| Olema Pharmaceuticals, Inc. | 39.95M |
| ADMA Biologics, Inc. | 1.528M |